Every year, more than 10,000 Americans are diagnosed with a specific type of cancer, called chronic lymphocytic leukemia.
This leukemia is tough to get rid of, and when patients become resistant to the treatments offered, there is not much a doctor can do.
Norman Zobel was diagnosed with chronic lymphocytic leukemia seven years ago.
He is now enrolled in a study on a new drug called Lenalidomide.
It has mild side effects and is a powerful player against leukemia that has grown resistant to other therapies.
The drug changes the environment around cancer cells, making it tough for the cells to survive.
It was effective in nearly half of people who had run out of treatment options.
Dr. Asher Chanan-Khan of the Rosewell Park Cancer Institute said, “We have several patients now, who actually, we cannot, in whom we cannot detect cancer anymore.”
Norman is one of them.
Lenalidomide is already FDA approved for the treatment of another cancer, called multiple myeloma.